A study of olezarsen in adults with hypertriglyceridaemia and atherosclerotic cardiovascular disease (ASCVD) and/or with severe hypertriglyceridaemia (sHTG) (Bridge-TIMI73a, NCT05355402)

Please login or create a FREE account to view this content

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo